热门资讯> 正文
守夜神经科学GAAP每股收益为-0.52美元
2024-08-13 20:35
- Vigil Neuroscience press release (NASDAQ:VIGL): Q2 GAAP EPS of -$0.52.
- Cash, cash equivalents, and marketable securities were $86.7 million as of June 30, 2024, compared to $101.6 million as of March 31, 2024.
More on Vigil Neuroscience
- Vigil Neuroscience reports interim data from its once-daily oral therapy for Alzheimer’s
- Biggest stock movers today: WBA, BB, MU, and more
- Seeking Alpha’s Quant Rating on Vigil Neuroscience
- Historical earnings data for Vigil Neuroscience
- Financial information for Vigil Neuroscience
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
